Utah Medical Products UTMD Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period?
- Utah Medical Products (UTMD) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 700 in Q4 2025.
- How has Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period changed year-over-year?
- Utah Medical Products's share-based compensation arrangement by share-based payment award, options, expirations in period decreased by 76.7% year-over-year, from 3K to 700.
- What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?
- The total value or volume of stock options that have expired during the reporting period without being exercised. This metric provides insight into the historical utilization of equity incentive plans and the potential reversal of previously recognized compensation expenses. It helps investors understand the lifecycle of employee equity awards.